Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 21,638 results that match your search.21,638 results
  • Recent changes to Italy's copyright laws have led to confusion about the scope of copyright enforcement. Stefano Modenesi and Giacomo Parmigiani of DLA look at available laws and examine their differences
  • Gabriel Cuonzo of Trevisan & Cuonzo examines how Italy's litigation landscape has changed after the death of the Italian torpedo and how legal changes could revamp the country's image on the European litigation scene
  • Italy's biotech sector is on the rise. Massimiliano Mostardini and Claudia Ricciardi of Bird & Bird provide an in-depth overview of Italian rules on biotech patents and employee inventions
  • A new IP code is being introduced in Italy. Luciano Bosotti and Giancarlo Notaro of Buzzi Notaro & Antonielli d'Oulx provide an in-depth look at Italy's existing patent prosecution system, how it compares with the EPC and how inventors can best benefit from it
  • The growth of counterfeiting, especially of pharmaceuticals, has raised the prospect of legitimate manufacturers becoming liable for damage caused by counterfeit products. Nick Beckett examines the lessons arising from such disputes in the US
  • The European Commission recently introduced stricter Customs rules to tackle rising piracy and counterfeiting rates. Cinzia Bricca, director of the Italian Customs Agency, tells Stéphanie Bodoni how things have changed for her team and Customs in general
  • In two landmark cases, the UK's House of Lords has tackled some of the fundamentals of English patent law. Alan Johnson, Alex Wilson and Ewan Nettleton review the Lords' findings and their implications for patent owners in Europe
  • Alain Pompidou takes over as president of the EPO as industry is becoming increasingly frustrated at the slow pace of patent reform in Europe. MIP visited Munich to ask him about his plans for the presidency. Interview introduced by James Nurton
  • In a landmark decision, the House of Lords has invalidated Amgen's key patent for erythropoietin. James Nurton examines the impact of the ruling
  • A frenzy of government-led reform in Japan is dramatically changing the IP regime in the country. Lloyd Parker and Yukihiro Otani provide a guide to the most important developments